Physician
Canton-Potsdam Hospital
Canton-Potsdam Hospital was paid $61.54M by Medicaid between Jan 2018 and Dec 2024, across 417 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 20% of everything it billed.
33Billing provider infoCANTON-POTSDAM HOSPITAL
POTSDAM, NY 13676
POTSDAM, NY 13676
33aNPI1568548782assigned 10/31/2006
33bProvider typeAnesthesiology Physician
28Total paid$61.54M
24GClaims1,000,207
24DCodes billed417
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in New York
Rank by total paid#1 of 493
Median peer was paid$8K
This provider vs. median7,992×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,207 | $551K | |
| 2019 | 61,444 | $2.90M | |
| 2020 | 148,819 | $6.83M | |
| 2021 | 194,353 | $9.56M | |
| 2022 | 194,974 | $16.42M | |
| 2023 | 217,475 | $14.96M | |
| 2024incomplete | 172,935 | $10.32M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 113,159 | 103,711 | $12.14M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 13% | 65,284 | 54,395 | $8.06M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 62,570 | 58,641 | $7.09M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.1% | 16,874 | 15,950 | $2.52M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.1% | 16,092 | 15,353 | $1.89M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.5% | 12,151 | 11,526 | $1.51M |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.3% | 5,250 | 4,507 | $1.40M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.2% | 16,197 | 5,717 | $1.38M |
| 36415 | Collection of venous blood by venipuncture | 2.0% | 38,339 | 31,319 | $1.26M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.8% | 10,897 | 10,138 | $1.09M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 1.7% | 6,828 | 3,982 | $1.03M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.6% | 9,257 | 9,173 | $970K |
405 more codes
| 99215 | Doctor's office visit, returning patient (complex) | 1.5% | 6,772 | $916K |
| 80053 | Comprehensive metabolic panel | 1.5% | 33,588 | $913K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.2% | 3,161 | $753K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.1% | 6,372 | $697K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 10,434 | $688K |
| 81025 | 1.1% | 8,144 | $667K | |
| 90837 | Psychotherapy session, about an hour | <1% | 4,075 | $572K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 3,010 | $549K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 4,077 | $521K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,729 | $509K |
| G0397 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes | <1% | 3,284 | $495K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 8,974 | $481K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,799 | $468K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 5,987 | $431K |
| 20610 | <1% | 2,124 | $410K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 3,275 | $408K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,469 | $404K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 311 | $399K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 615 | $380K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,672 | $315K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,556 | $311K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 8,652 | $299K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 9,804 | $296K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 695 | $287K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 9,588 | $272K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,333 | $266K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 2,245 | $240K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 7,967 | $223K |
| 97162 | <1% | 1,574 | $217K | |
| 59025 | Fetal non-stress test | <1% | 1,844 | $214K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 6,456 | $209K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 796 | $203K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,258 | $201K |
| 17110 | <1% | 655 | $198K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 2,102 | $171K |
| 29848 | <1% | 314 | $169K | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 1,463 | $166K |
| 87486 | <1% | 1,891 | $153K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,769 | $151K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 507 | $148K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 2,128 | $142K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,385 | $140K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,149 | $127K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,699 | $125K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,157 | $122K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 778 | $122K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,744 | $120K |
| 97161 | <1% | 1,075 | $116K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 7,902 | $116K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,313 | $113K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,473 | $107K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,438 | $105K |
| 88142 | <1% | 3,462 | $103K | |
| 86850 | <1% | 2,674 | $99K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 2,040 | $98K |
| 90686 | <1% | 4,443 | $97K | |
| 80061 | Lipid panel | <1% | 10,238 | $97K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 2,294 | $94K |
| 96415 | <1% | 211 | $88K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 652 | $85K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,267 | $81K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,149 | $77K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 94 | $77K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 1,477 | $76K |
| 76830 | Ultrasound, transvaginal | <1% | 1,595 | $74K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 3,053 | $72K |
| 90715 | <1% | 2,567 | $69K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 391 | $68K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 563 | $67K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12,388 | $66K |
| H0001 | Alcohol and/or drug assessment | <1% | 400 | $66K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 911 | $65K |
| 97010 | <1% | 3,090 | $64K | |
| 97035 | <1% | 1,343 | $61K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,490 | $61K |
| 95886 | <1% | 699 | $60K | |
| G0378 | Hospital observation service, per hour | <1% | 1,583 | $57K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 7,804 | $56K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,936 | $54K |
| 86900 | <1% | 2,088 | $54K | |
| S5161 | Emergency response system; service fee, per month (excludes installation and testing) | <1% | 1,793 | $51K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 782 | $50K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 173 | $49K |
| 83880 | <1% | 1,655 | $49K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,893 | $47K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 32,775 | $46K |
| 76801 | <1% | 548 | $44K | |
| 90647 | <1% | 2,505 | $43K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 141 | $43K |
| 90651 | <1% | 713 | $40K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,641 | $37K |
| 87581 | <1% | 1,891 | $36K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 154 | $36K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 595 | $35K |
| 83655 | <1% | 2,508 | $35K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 2,693 | $34K |
| 97165 | <1% | 323 | $34K | |
| 90677 | <1% | 1,049 | $31K | |
| 93017 | <1% | 413 | $31K | |
| 31231 | <1% | 358 | $30K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 288 | $30K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 89 | $29K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 502 | $29K |
| 82607 | <1% | 3,177 | $29K | |
| 90633 | <1% | 1,968 | $26K | |
| 90723 | <1% | 2,579 | $26K | |
| 86901 | <1% | 1,571 | $25K | |
| 88342 | <1% | 119 | $25K | |
| 84439 | <1% | 4,950 | $25K | |
| 99442 | <1% | 391 | $24K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 466 | $24K |
| 99385 | <1% | 162 | $24K | |
| 86480 | <1% | 365 | $23K | |
| 71250 | <1% | 189 | $22K | |
| 90750 | <1% | 148 | $22K | |
| 99443 | <1% | 336 | $22K | |
| 82728 | <1% | 2,657 | $22K | |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 110 | $22K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 210 | $21K |
| 76641 | <1% | 624 | $21K | |
| 99406 | <1% | 466 | $20K | |
| 99441 | <1% | 471 | $20K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,805 | $20K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 12 | $20K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 8,070 | $18K |
| 86618 | <1% | 2,247 | $18K | |
| 12001 | <1% | 41 | $18K | |
| 90670 | <1% | 2,710 | $17K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 192 | $17K |
| 93971 | <1% | 386 | $17K | |
| 17000 | <1% | 70 | $16K | |
| 84153 | <1% | 1,076 | $16K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 77 | $16K |
| 90656 | <1% | 707 | $16K | |
| S9480 | Intensive outpatient psychiatric services, per diem | <1% | 140 | $15K |
| 84702 | <1% | 3,182 | $15K | |
| 90681 | <1% | 1,630 | $15K | |
| 88304 | <1% | 600 | $15K | |
| 82803 | <1% | 940 | $14K | |
| 90696 | <1% | 592 | $14K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,317 | $13K |
| 97803 | <1% | 480 | $13K | |
| 20553 | <1% | 187 | $13K | |
| 90619 | <1% | 413 | $13K | |
| 20550 | <1% | 47 | $12K | |
| 95117 | <1% | 483 | $12K | |
| 11102 | <1% | 25 | $12K | |
| 90707 | <1% | 843 | $11K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 127 | $11K |
| 76770 | <1% | 41 | $11K | |
| 90710 | <1% | 697 | $11K | |
| 82962 | <1% | 2,917 | $10K | |
| 85610 | <1% | 4,126 | $10K | |
| 86803 | <1% | 2,397 | $10K | |
| 87468 | <1% | 295 | $10K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 156 | $9K |
| 86140 | <1% | 8,085 | $9K | |
| 86780 | <1% | 1,964 | $9K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,562 | $9K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | <1% | 15 | $9K |
| G0008 | Administration of influenza virus vaccine | <1% | 726 | $9K |
| 83540 | <1% | 2,482 | $8K | |
| 80076 | <1% | 602 | $8K | |
| 90716 | <1% | 737 | $8K | |
| 94060 | <1% | 69 | $7K | |
| 84403 | <1% | 408 | $7K | |
| 84481 | <1% | 1,295 | $7K | |
| 87340 | <1% | 1,776 | $7K | |
| 72141 | <1% | 25 | $7K | |
| 83550 | <1% | 2,103 | $7K | |
| 85027 | <1% | 3,301 | $7K | |
| 90675 | <1% | 39 | $6K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 173 | $6K |
| 82570 | <1% | 2,326 | $6K | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 51 | $6K |
| 90700 | <1% | 753 | $6K | |
| 94010 | <1% | 72 | $6K | |
| 83735 | <1% | 3,543 | $6K | |
| 86481 | <1% | 143 | $6K | |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 50 | $6K |
| 86666 | <1% | 1,444 | $6K | |
| 74018 | <1% | 1,274 | $6K | |
| 90688 | <1% | 155 | $6K | |
| 86762 | <1% | 887 | $6K | |
| 87469 | <1% | 294 | $6K | |
| 87484 | <1% | 295 | $6K | |
| 87186 | <1% | 2,727 | $6K | |
| 82746 | <1% | 756 | $5K | |
| 86812 | <1% | 128 | $5K | |
| 76536 | <1% | 193 | $5K | |
| 87478 | <1% | 281 | $5K | |
| 82043 | <1% | 1,669 | $5K | |
| 95911 | <1% | 63 | $5K | |
| 96367 | <1% | 67 | $5K | |
| 82670 | <1% | 293 | $5K | |
| 87070 | <1% | 1,284 | $4K | |
| 73110 | <1% | 1,541 | $4K | |
| 73221 | <1% | 13 | $4K | |
| 87077 | <1% | 1,437 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,435 | $4K |
| 90697 | <1% | 163 | $4K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,908 | $4K |
| 86753 | <1% | 413 | $4K | |
| 82784 | <1% | 534 | $4K | |
| 82947 | <1% | 1,691 | $4K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 12 | $4K |
| 84146 | <1% | 386 | $4K | |
| 87081 | <1% | 2,517 | $4K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 129 | $3K |
| 83001 | <1% | 312 | $3K | |
| 71271 | <1% | 92 | $3K | |
| 73030 | <1% | 1,391 | $3K | |
| 73630 | <1% | 2,172 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 473 | $3K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 41 | $3K |
| 81001 | <1% | 4,487 | $3K | |
| 85730 | <1% | 3,038 | $3K | |
| 87507 | <1% | 27 | $3K | |
| 86038 | <1% | 1,160 | $3K | |
| 86431 | <1% | 1,193 | $3K | |
| 87522 | Neg quan hep c or qual rna | <1% | 76 | $3K |
| 91320 | <1% | 25 | $3K | |
| 97760 | <1% | 52 | $3K | |
| 73610 | <1% | 1,674 | $3K | |
| 84144 | <1% | 170 | $3K | |
| 81015 | <1% | 4,423 | $3K | |
| 64493 | <1% | 46 | $3K | |
| 87480 | <1% | 1,554 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,161 | $3K |
| 73130 | <1% | 1,469 | $3K | |
| 87660 | <1% | 1,590 | $3K | |
| 64635 | <1% | 104 | $3K | |
| 90620 | <1% | 64 | $2K | |
| 86787 | <1% | 753 | $2K | |
| 99383 | <1% | 12 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 455 | $2K |
| 94618 | <1% | 13 | $2K | |
| 86003 | <1% | 459 | $2K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 16 | $2K |
| 73564 | <1% | 577 | $2K | |
| 85652 | <1% | 2,422 | $2K | |
| 58300 | <1% | 14 | $2K | |
| 76775 | <1% | 29 | $2K | |
| 90680 | <1% | 83 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 77 | $2K |
| 99386 | <1% | 14 | $2K | |
| 87510 | <1% | 1,520 | $2K | |
| 92133 | <1% | 26 | $2K | |
| G0009 | Administration of pneumococcal vaccine | <1% | 169 | $2K |
| 90734 | <1% | 316 | $2K | |
| 86329 | <1% | 232 | $2K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 3,643 | $2K |
| 84550 | <1% | 768 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,826 | $2K |
| 85651 | <1% | 1,849 | $2K | |
| 82248 | <1% | 770 | $2K | |
| 85379 | <1% | 1,650 | $2K | |
| 83690 | <1% | 6,645 | $2K | |
| 86160 | <1% | 537 | $2K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 795 | $2K |
| 69210 | <1% | 51 | $2K | |
| 70486 | <1% | 12 | $1K | |
| 87631 | <1% | 28 | $1K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 15 | $1K |
| 36591 | <1% | 61 | $1K | |
| 0001A | <1% | 117 | $1K | |
| 73140 | <1% | 609 | $1K | |
| 62323 | <1% | 24 | $1K | |
| 94727 | <1% | 81 | $1K | |
| 86039 | <1% | 473 | $1K | |
| 83615 | <1% | 583 | $1K | |
| 72110 | <1% | 103 | $1K | |
| 86617 | <1% | 158 | $1K | |
| 99460 | <1% | 13 | $1K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 29 | $1K |
| 73502 | <1% | 493 | $1K | |
| 81003 | <1% | 3,703 | $1K | |
| 99382 | <1% | 12 | $1K | |
| 11721 | <1% | 50 | $1K | |
| 86709 | <1% | 254 | $1K | |
| 17004 | <1% | 16 | $1K | |
| 81002 | <1% | 6,160 | $1K | |
| 0002A | <1% | 115 | $1K | |
| 83002 | <1% | 83 | $988.13 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 12 | $979.34 |
| 73562 | <1% | 817 | $976.14 | |
| 94729 | <1% | 84 | $969.93 | |
| 93246 | <1% | 12 | $953.63 | |
| 84484 | <1% | 6,091 | $916.96 | |
| 84402 | <1% | 53 | $867.73 | |
| 82105 | <1% | 214 | $866.64 | |
| 73560 | <1% | 615 | $863.93 | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,993 | $831.10 |
| 87040 | <1% | 2,346 | $827.19 | |
| 86706 | <1% | 159 | $817.49 | |
| 86225 | <1% | 513 | $810.72 | |
| 72100 | <1% | 280 | $774.81 | |
| 80320 | <1% | 1,006 | $767.41 | |
| 90480 | <1% | 22 | $760.00 | |
| 86200 | <1% | 357 | $738.74 | |
| 84100 | <1% | 282 | $729.43 | |
| 31575 | <1% | 12 | $704.42 | |
| 86778 | <1% | 105 | $696.56 | |
| 86235 | <1% | 221 | $687.58 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,644 | $684.27 |
| 85018 | <1% | 536 | $675.22 | |
| 86705 | <1% | 168 | $663.54 | |
| 86704 | <1% | 152 | $658.95 | |
| 90381 | <1% | 31 | $602.40 | |
| 86777 | <1% | 75 | $599.01 | |
| 73080 | <1% | 110 | $515.30 | |
| 95251 | <1% | 25 | $513.71 | |
| 82550 | <1% | 460 | $513.29 | |
| 85007 | <1% | 610 | $501.18 | |
| 99407 | <1% | 39 | $485.18 | |
| 97750 | <1% | 16 | $436.15 | |
| 84703 | <1% | 3,102 | $425.14 | |
| 85014 | <1% | 290 | $421.06 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,567 | $391.44 |
| 97802 | <1% | 12 | $390.34 | |
| 93225 | <1% | 13 | $372.14 | |
| 84460 | <1% | 99 | $366.28 | |
| 0071A | <1% | 61 | $360.00 | |
| 0072A | <1% | 53 | $360.00 | |
| 83605 | <1% | 3,230 | $354.74 | |
| 82950 | <1% | 151 | $334.49 | |
| 92083 | <1% | 12 | $333.84 | |
| 84450 | <1% | 83 | $307.83 | |
| 90380 | <1% | 13 | $301.20 | |
| 73090 | <1% | 57 | $260.64 | |
| 84156 | <1% | 247 | $259.90 | |
| 84155 | <1% | 228 | $231.09 | |
| 83516 | <1% | 91 | $228.07 | |
| 86769 | <1% | 16 | $206.83 | |
| 83520 | <1% | 43 | $185.52 | |
| 90662 | <1% | 15 | $176.68 | |
| 99173 | <1% | 2,751 | $148.21 | |
| 84165 | <1% | 52 | $146.98 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,142 | $145.79 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,309 | $142.23 |
| 73590 | <1% | 125 | $133.30 | |
| 86308 | <1% | 99 | $130.37 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,977 | $123.76 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 195 | $123.35 |
| 0004A | <1% | 44 | $120.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,961 | $118.03 |
| 86376 | <1% | 24 | $116.40 | |
| 87807 | <1% | 172 | $115.94 | |
| 72040 | <1% | 52 | $114.33 | |
| 88141 | <1% | 18 | $113.06 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,906 | $96.76 |
| 82977 | <1% | 28 | $91.44 | |
| 96376 | <1% | 1,037 | $90.16 | |
| 87430 | <1% | 628 | $88.13 | |
| 82948 | <1% | 992 | $82.19 | |
| 86255 | <1% | 16 | $73.64 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 63 | $73.46 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,455 | $65.38 |
| 86708 | <1% | 14 | $63.13 | |
| 80305 | <1% | 420 | $60.52 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 920 | $59.95 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,905 | $56.65 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,029 | $55.30 |
| 71101 | <1% | 12 | $49.22 | |
| 82565 | <1% | 14 | $40.24 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 816 | $37.82 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 380 | $36.29 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 487 | $36.12 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 107 | $31.38 |
| 86141 | <1% | 13 | $30.75 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 589 | $28.42 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 197 | $28.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 453 | $23.50 |
| 80348 | <1% | 16 | $20.00 | |
| 84480 | <1% | 12 | $17.10 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 194 | $16.01 |
| 80143 | <1% | 112 | $13.05 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,696 | $12.82 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 27 | $7.20 |
| 73070 | <1% | 15 | $6.06 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 102 | $5.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 1,033 | $4.12 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 168 | $3.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 210 | $3.00 |
| A9270 | Non-covered item or service | <1% | 253 | $0.90 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 85 | $0.81 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 128 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 26 | $0.00 |
| 94799 | 0% | 13 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 14 | $0.00 |
| 99152 | 0% | 50 | $0.00 | |
| 80179 | 0% | 70 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 16 | $0.00 |
| C1729 | Catheter, drainage | 0% | 27 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 36 | $0.00 |
| 84145 | 0% | 36 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 128 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 257 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 72 | $0.00 |
| 80329 | 0% | 559 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 56 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 64 | $0.00 |
| 96380 | 0% | 16 | $0.00 | |
| 87205 | 0% | 12 | $0.00 | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCGREGOR, DONNA (CFO)
| Provider | Location | Paid |
|---|---|---|
| Gouverneur Hospital | Gouverneur, NY | $12.66M |
| Gouverneur Hospital | Gouverneur, NY | $246K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.